AH
Asad Haider Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
44.4%
Neutral
44.4%
Negative
11.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Upgraded
| $142 |
56%
upside
| 2 | -14% |
0
%
| 16 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $240 |
2%
upside
| 3 | +18% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $37 |
21%
upside
| 2 | – |
–
| 2 Dec ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $57 |
1%
upside
| 2 | – |
–
| 2 Dec ‘25 6 months ago |
|
|
|
Sell
Initiated
| $17 |
24%
downside
| 1 | -17% |
0
%
| 30 Sep ‘25 8 months ago |
|
|
|
Buy
Initiated
| $42 |
23%
downside
| 1 | +32% |
0
%
| 30 Sep ‘25 8 months ago |
|
|
|
Neutral
Initiated
| $38 |
23%
downside
| 1 | – |
–
| 12 Sep ‘25 9 months ago |
|